Brown, Lisle/Cummings’s Dorman Products DORM Stock Holding History

Brown, Lisle/Cummings’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.46K	Sell	18 -2	-10%	-$237	﹤0.01%	819
2026 Q1	$2.09K	Buy	+20	New	+$2.38K	﹤0.01%	809

Other funds holding DORM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

KTF Investments Seal Beach, California $989M AUM

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown, Lisle/Cummings's DORM Position: Q2 2026 in Review

Brown, Lisle/Cummings reduced its Dorman Products (DORM) stake by 10% in Q2 2026, selling an estimated $237 and leaving 18 shares worth $2.46K. The position accounts for ﹤0.01% of the portfolio, ranked #819.

Brown, Lisle/Cummings first reported a position in DORM in Q1 2026 and has held it in 2 quarters since. 329 funds tracked by Wall St. Rank hold DORM as of Q2 2026.

Brown, Lisle/Cummings held 18 shares of Dorman Products worth $2.46K as of Q2 2026.
Brown, Lisle/Cummings sold 2 Dorman Products shares in Q2 2026, an estimated $237.
Dorman Products made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #819 holding.
Brown, Lisle/Cummings first reported a position in Dorman Products in Q1 2026 and has held it in 2 quarters since.
329 funds tracked by Wall St. Rank held Dorman Products as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.